cladribine has been researched along with Pregnancy in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Haug, U; Kollhorst, B; Platzbecker, K; Wentzell, N | 1 |
| Ciplea, AI; Dost-Kovalsky, K; Gold, R; Hellwig, K; Thiel, S | 1 |
| Comi, G; Cook, S; Damian, D; Dangond, F; Galazka, A; Giovannoni, G; Leist, T; Montalban, X; Schick, R | 1 |
| Callegari, I; Derfuss, T; Galli, E | 1 |
| Becker, V; Elias-Hamp, B; Grothe, C; Havla, J; Pul, R; Rau, D; Richter, S; Schmidt, S; Stangel, M | 1 |
| Schmidt, S | 1 |
| Daver, N; Haltom, R; Kantarjian, HM; Nazha, A; Ravandi, F | 1 |
| Best, D; Knudsen, TB; Lau, C; Lui, D; Mann, PC; Narotsky, MG; Setzer, RW; Wubah, JA | 1 |
| Orlowski, RZ | 1 |
| Elinder, G; Kimby, E; Sverrisdottir, A | 1 |
| Andrychowski, J; Grieb, P; Jagielski, J; Janczewski, W; Ryba, M; Sawicki, J | 1 |
| Alothman, A; Sparling, TG | 1 |
| Andrychowski, J; Grieb, P; Jagielski, J; Janczewski, WA; Janisz, M; Mantuzyk, J; Ryba, M; Sawicki, J | 1 |
| Birtolo, S; Lauria, F; Lenoci, M; Marotta, G; Nardi, G; Raspadori, D; Rondelli, D; Scalia, G; Sestigiani, C; Tozzi, M | 1 |
| Callen, JP | 1 |
5 review(s) available for cladribine and Pregnancy
| Article | Year |
|---|---|
Update on treatment in multiple sclerosis.
Topics: Abnormalities, Drug-Induced; Algorithms; Antibodies, Monoclonal, Humanized; Cladribine; Crotonates; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hematopoietic Stem Cell Transplantation; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Indans; Interferon-beta; Male; Mitoxantrone; Multiple Sclerosis; Natalizumab; Nitriles; Oxadiazoles; Pregnancy; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Toluidines | 2021 |
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practice.
Topics: Cladribine; Expert Testimony; Female; Humans; Immunosuppressive Agents; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Neurologists; Pregnancy; Tablets | 2021 |
Cladribine (Mavenclad) for multiple sclerosis.
Topics: Adult; Cladribine; Drug Costs; Female; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Pregnancy; Randomized Controlled Trials as Topic | 2019 |
[Oral cladribine for relapsing-remitting multiple sclerosis: another purine analogue or a genuine therapeutic innovation?].
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Animals; Azathioprine; Cladribine; Clinical Trials, Phase III as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Long-Term Care; Lymphopenia; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neoplasms; Pregnancy; Purine Nucleosides; Randomized Controlled Trials as Topic; Thrombocytopenia | 2010 |
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Chlorambucil; Cladribine; Cyclophosphamide; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Skin Diseases; Thioguanine | 2001 |
12 other study(ies) available for cladribine and Pregnancy
| Article | Year |
|---|---|
Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany.
Topics: Child; Cladribine; Cross-Sectional Studies; Drug Utilization; Female; Fingolimod Hydrochloride; Germany; Humans; Immunosuppressive Agents; Infant, Newborn; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Pregnancy | 2022 |
Cladribine and pregnancy in women with multiple sclerosis: The first cohort study.
Topics: Cladribine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Pregnancy; Pregnancy Outcome; Recurrence | 2023 |
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Cladribine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Male; Meta-Analysis as Topic; Multiple Sclerosis; Pregnancy; Pregnancy Outcome; Registries; Young Adult | 2020 |
Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Administration Schedule; Female; Humans; Leukemia, Hairy Cell; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab | 2013 |
Exposure-disease continuum for 2-chloro-2'-deoxyadenosine (2-CdA), a prototype teratogen: induction of lumbar hernia in the rat and species comparison for the teratogenic responses.
Topics: Animals; Cladribine; Dose-Response Relationship, Drug; Eye Abnormalities; Female; Hernia; Lumbosacral Region; Pregnancy; Rats; Rats, Sprague-Dawley; Spinal Cord Diseases; Teratogens | 2002 |
Successful pregnancy after cladribine therapy for hairy cell leukemia.
Topics: Adult; Cladribine; Female; Humans; Leukemia, Hairy Cell; Pregnancy; Time Factors | 2004 |
Safety of rituximab therapy during the first trimester of pregnancy: a case history.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cladribine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Lymphoma, Follicular; Male; Methotrexate; Mitoguazone; Peripheral Blood Stem Cell Transplantation; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, First; Remission Induction; Rituximab; Safety; Transplantation, Autologous; Vincristine | 2004 |
2-Chloro-2'-deoxyadenosine (2-CdA) combined with cyclosporine A successfully prevents rejection of fetal brain stem allograft in rabbits.
Topics: Animals; Brain Stem; Brain Tissue Transplantation; Cladribine; Cyclosporine; Electrophysiology; Female; Fetal Tissue Transplantation; Graft Rejection; Immunosuppressive Agents; Male; Pregnancy; Rabbits | 1994 |
Managing hairy cell leukemia in pregnancy.
Topics: Adult; Cladribine; Female; Humans; Leukemia, Hairy Cell; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome | 1994 |
New drug bulletin. Cladribine injection (leustatin).
Topics: Adult; Child; Cladribine; Drug Interactions; Female; Humans; Leukemia, Hairy Cell; Patient Education as Topic; Pregnancy | 1994 |
Survival and maturation of heterotopic fetal brain stem xenografts after treatment with 2-chlorodeoxyadenosine and cyclosporine A.
Topics: Animals; Brain Stem; Brain Tissue Transplantation; Cladribine; Cyclosporine; Female; Fetal Tissue Transplantation; Graft Survival; Immunosuppressive Agents; Myelin Basic Protein; Phosphopyruvate Hydratase; Pregnancy; Rabbits; Rats; Rats, Wistar; Transplantation, Heterologous | 1995 |
Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment.
Topics: Adult; Aged; Antineoplastic Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cladribine; Female; Humans; Leukemia, Hairy Cell; Leukocyte Common Antigens; Male; Middle Aged; Pregnancy; Time Factors | 1999 |